Dr Martin Osugo earns global recognition in neuropsychopharmacology
Published: 20 May 2026
Alumnus Dr Martin Osugo awarded the Rafaelsen Young Investigator Award from the International College of Neuropsychopharmacology.
Dr Martin Osugo (BSc (MedSci) 2015, MBChB 2017) has received the Rafaelsen Young Investigator Award from the International College of Neuropsychopharmacology (CINP).
The award is presented annually to just three researchers worldwide who are within 10 years of completing their PhD, and recognises outstanding contributions to the field of neuropsychopharmacology.
Dr Osugo has also been recognised by the British Association for Psychopharmacology's (BAP) Junior Translational Psychopharmacology Award, given annually to a single early to mid-career researcher for outstanding work in translational psychopharmacology.
Dr Osugo, now based at King’s College London, focused his PhD on the effect of antipsychotic medications on cognition, including motivation and reward processing. His work has also been recognised through the Dennis Hill Poster Prize for his ground-breaking research in schizophrenia. You can read Martin’s interview about his Dennis Hill Poster Prize with the South London and Maudsley NHS Foundation Trust here.
In a fitting, full-circle moment, Dr Osugo will return to Glasgow this summer to receive the award at the CINP annual meeting.
Reflecting, Dr Osugo added:
“It’s particularly special to be returning to Glasgow to receive this award. My time at the University of Glasgow gave me a strong foundation in research and clinical medicine, and it feels very meaningful to come back at this stage in my career.”
The award marks an important milestone in Dr Osugo’s career dedicated to improving the understanding of mental health, as he contributes to research that has the potential to make a lasting difference to patients worldwide.
You can find out more about Dr Osugo's work here.
First published: 20 May 2026
<< Noticeboard
